EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 52 days ( 0 % )
Last Price $0.0400 0 %
High/ Low $0.0400 - $0.0400 0%
Chg 7 Days N/A $0.0400 $0.0400
Chg 30 Days N/A $0.0400 $0.0400
Chg 12 mos -27.27 % $0.0550 $0.0400
Trend - 3 mos -7.87 % Width: 40.57 %
Trend - 12 mos -39.79 % Width: 250.77 %
Pred. range - 3 mos $0.0333 - $0.0467 -16.86 % - 16.87 %
Pred. range - 12 mos $0.0082 - $0.0288 -79.51 % - -28.11 %
Short MA avg 3 mos Sell Mar 28, 2024 - 60 days
Long MA avg 3 mos Sell Apr 03, 2024 - 57 days
Short/Long MA avg 3 mos Sell Apr 08, 2024 - 54 days
Short MA avg 12 mos Sell Apr 03, 2024 - 57 days
Long MA avg 12 mos Sell Mar 28, 2024 - 60 days
Short/Long MA avg 12 mos Sell Oct 06, 2023 - 178 days
Pivot Short Buy Mar 27, 2024 - 61 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About StageZero Life Sciences Ltd

StageZero Life Sciences Ltd StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a ... SZLS.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT